China Resources Pharmaceutical Group Limited (HKG:3320)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Elimination of Inter-Segment Sales	-13.85B	-12.07B	-10.57B	-8.89B	-7.09B
Others	93.25M	73.58M	76.36M	35.02M	133.55M
Manufacturing	51.04B	46.32B	43.46B	38.03B	31.46B
Retail	12.21B	10.10B	9.58B	7.59B	6.20B
Distribution	220.08B	213.24B	202.15B	181.42B	162.22B
Total	269.57B	257.67B	244.70B	218.18B	192.92B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	268.51B	256.14B	243.11B	216.95B	192.41B
Others	1.07B	1.54B	1.59B	1.23B	-
Hong Kong	-	-	-	-	512.25M
Total	269.57B	257.67B	244.70B	218.18B	192.92B

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error